An official journal of the Association of Transitional Oncology launched for the first time in India
To mark the National Cancer Awareness Day, HCG – The Specialist in Cancer Care launched the first edition of the Journal of Precision Oncology. The journal is developed in association with Wolters Kluwer and ATRO – Association for transitional research in oncology. This is the first of its kind journal in India and the second in the world to be launched.
The Journal of Precision Oncology aims at building upon the current understanding of cancer in a manner that treats each type of cancer and each patient as a unique case, such that care strategies can be tailor-made to cater to this uniqueness while adhering to evidence-based practices. It is the official semi-annual publication of HCG, available both online and in print formats.
Precision medicine is an emerging approach that takes into account genetic, biologic, metabolomics, proteomics, and transcriptomic variability of every individual and creates specific treatment strategies. This approach allows doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease. It is in contrast to a one-size-fits-all approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.